Breaks Categories: News

TuesdayMar 24, 2020 10:05 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Participate in Life Sciences Investor Forum’s Virtual Conference

Life Sciences Investor Forum today announced the schedule for its inaugural event for both public and private companies, investors and worldwide industry professionals. The one-day event is kicking off on Thursday, March 26 with the first live webcast at 9:30 AM ET. Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is scheduled to provide a presentation at 12:00 PM ET on March 26. Per the release, pre-registration is recommended for investors and it is encouraged that they run the online system check to expedite participation and receive event updates. There is no cost to view…

Continue Reading

TuesdayMar 24, 2020 9:51 am

CannabisNewsBreaks – No Borders, Inc.’s (NBDR) MediDent Supplies Announces New Stay at Home 15 Minute Rapid Result COVID-19 Blood Tests

No Borders (OTC: NBDR) on Monday announced that the Company has executed an agreement with its existing suppliers in Hong Kong to bring its 15 minute “At Home” Serological COVID-19 test to the USA. According to the update, the brand new “MediDent Supplies 15 Minute Rapid Result Covid-19 Test” is being manufactured by a MediDent Supplies partner with existing U.S. FDA registrations for both the manufacturer and the serological test kit itself. MediDent Supplies is actively engaged with the FDA to obtain an Emergency Use Authorization for its COVID-19 blood test and believes it will receive expedited approval due to…

Continue Reading

MondayMar 23, 2020 12:55 pm

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) CEO Shares Strategic Goals in Exclusive Audio Interview

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the broadcast of its audio interview with NetworkNewsAudio (“NNA”), one of 40+ brands in the InvestorBrandNetwork (“IBN”). In the interview, Champignon Brands CEO Gareth Birdsall joins NNW’s Stuart Smith to delve into the company’s strategic plan to expand its portfolio and become a preeminent player in the emerging psychedelic medicine arena. “We’ve achieved some pretty impressive sales from around the globe, revamped our e-commerce website, as well as commenced certain research and development initiatives,” Birdsall said, noting Champignon recently completed an initial public offering…

Continue Reading

MondayMar 23, 2020 11:51 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Expansion of Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced expansion of the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp. According to the update, Lexaria Pharmaceutical will investigate how the company’s patented DehydraTECH(TM) drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories across North America and internationally as soon as possible. To view the full press release, visit http://cnw.fm/4NW8h About Lexaria Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its…

Continue Reading

FridayMar 20, 2020 1:33 pm

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) Announces Intent to Commence Normal Course Issuer Bid

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced its intent to commence a normal course issuer bid (“NCIB”) to purchase up to a total of 2,411,883 common shares, representing 5% percent of the issued and outstanding common shares of the company as of March 20, 2020. Per the news release, Champignon believes that current market conditions have resulted in its shares being undervalued relative to the immediate and long-term value of its vertically integrated portfolio of alternative medicine products. Pursuant to the NCIB, the company may purchase the common shares through the…

Continue Reading

FridayMar 20, 2020 11:42 am

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Issues Operations Update Regarding COVID-19

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that the company, its production facilities and medical clinics are all continuing to react to COVID-19 with adjustments to internal business practices consistent with the guidelines of public health authorities. Among other highlights from the update, the company reported that it is encouraging all to suspend travel, work from home when possible, and increase the use of personal protective equipment to lessen the risk of COVID-19 exposure and spread. VIVO Cannabis has also implemented more rigorous cleaning and sanitization practices across all of its sites. At the time of the news release,…

Continue Reading

FridayMar 20, 2020 10:03 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Interview to Air on Bloomberg International on the RedChip Money Report

SinglePoint (OTCQB: SING) today announced that an interview with its president Will Ralston will air on The RedChip Money Report television program. According to the update, the exclusive interview will feature Ralston as he provides insight into the company's rapidly growing solar business for residential and commercial customers. The interview will air on Sunday, March 22, at 3 PM local time on Bloomberg International, available in 100+ million homes across Europe. "The RedChip Money Report" features financial book reviews and interviews with Wall Street analysts and executives of public companies and offers insightful commentary on small-cap investing. To view the…

Continue Reading

ThursdayMar 19, 2020 3:29 pm

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) Inks Agreement to Acquire Novo Formulations, Broadens Alternative Medicine Portfolio

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the expansion of its vertically integrated, alternative medicine product portfolio with the addition of new proprietary intellectual property (“IP”). SHRM recently entered into a definitive agreement, signed March 18, 2020, to acquire Novo Formulations Ltd. (“Novoformulations”), a specialty biotechnology company focused on developing novel and innovative delivery systems for the pharmaceutical and nutraceutical industries. Per the terms of the agreement, Champignon will acquire 100% of the issued and outstanding shares of Novoformulations for a total consideration of 12.5 million common shares in the capital…

Continue Reading

ThursdayMar 19, 2020 10:44 am

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Turns Up the Lights, Continues to Expand While Others Retrench in California Market

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. and California cannabis marketplaces, today announced another milestone at the company’s licensed cultivation operation in northern California, NUGS Farm North. According to the update, the company continues to expand operations and has now installed 768 high-powered grow lights, which will allow for an increase in the number of plants cultivated per year and an increase in yield relative to previously allocated cultivation capacity. “We are extremely excited to reach this milestone for NUGS Farm. It takes a lot of dedication, planning, and adjustments to get to this point.  Compliance…

Continue Reading

ThursdayMar 19, 2020 9:40 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Releases Shareholder Letter Discussing COVID-19 and Strategic Changes

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading branded cannabis products company based in California, today released a letter from its Co-founder and CEO, Jake Heimark, discussing the COVID-19 pandemic and recent company developments. “We do not know how COVID-19 will affect our business, but we believe that we are well prepared to respond to this crisis. For our company’s full response and real-time updates on the actions we are taking to respond to this crisis, please visit PlusProductsInc.com/coronavirus,” Heimark stated in the letter. “PLUS continues to have a strong foundation as a leader in the California cannabis market. We…

Continue Reading